chr18-47156209-T-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_016097.5(IER3IP1):c.217A>G(p.Ile73Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000319 in 1,568,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I73T) has been classified as Uncertain significance.
Frequency
Consequence
NM_016097.5 missense
Scores
Clinical Significance
Conservation
Publications
- microcephaly, epilepsy, and diabetes syndrome 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- primary microcephaly-epilepsy-permanent neonatal diabetes syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IER3IP1 | ENST00000256433.6 | c.217A>G | p.Ile73Val | missense_variant | Exon 3 of 3 | 1 | NM_016097.5 | ENSP00000256433.3 | ||
| ENSG00000267228 | ENST00000588705.1 | n.217A>G | non_coding_transcript_exon_variant | Exon 3 of 6 | 2 | ENSP00000465194.1 | ||||
| ENSG00000267228 | ENST00000602459.6 | n.92-19760A>G | intron_variant | Intron 1 of 6 | 5 | ENSP00000473358.1 | ||||
| ENSG00000267228 | ENST00000602926.5 | n.92-19760A>G | intron_variant | Intron 1 of 2 | 2 | ENSP00000473502.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151866Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000802 AC: 2AN: 249400 AF XY: 0.00000742 show subpopulations
GnomAD4 exome AF: 0.00000282 AC: 4AN: 1416746Hom.: 0 Cov.: 26 AF XY: 0.00000283 AC XY: 2AN XY: 707044 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151866Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74168 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Microcephaly, epilepsy, and diabetes syndrome Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 73 of the IER3IP1 protein (p.Ile73Val). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with IER3IP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 581459). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at